DexCom, Inc. Share Price Today: Live Updates & Key Insights

DexCom, Inc. share price today is $67.09, up -0.48%. The stock opened at $67.51 against the previous close of $67.27, with an intraday high of $67.89 and low of $66.

DexCom, Inc. Share Price Chart

DexCom, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

DexCom, Inc. Share Price Performance

$67.09 -0.0048(-0.48%) DXCM at 23 Mar 2026 12:48 PM Medical Devices
Lowest Today 66
Highest Today 67.89
Today’s Open 67.51
Prev. Close 67.27
52 Week High 89.98
52 Week Low 54.11
Day’s Range: Low 66 High 67.89
52-Week Range: Low 54.11 High 89.98
1 day return -
1 Week return +0.88
1 month return -8.65
3 month return -0.66
6 month return -3.73
1 year return -11.12
3 year return -41.75
5 year return -25.59
10 year return -

DexCom, Inc. Institutional Holdings

Vanguard Group Inc 12.75

BlackRock Inc 10.09

State Street Corp 4.38

Baillie Gifford & Co Limited. 4.04

JPMorgan Chase & Co 3.23

Vanguard Total Stock Mkt Idx Inv 3.19

Geode Capital Management, LLC 2.86

Vanguard 500 Index Investor 2.58

Vanguard Mid Cap Index Institutional 2.19

Invesco QQQ Trust 2.15

UBS Asset Mgmt Americas Inc 1.94

NORGES BANK 1.89

Jennison Associates LLC 1.50

Vanguard Growth Index Investor 1.34

iShares Core S&P 500 ETF 1.29

Fidelity 500 Index 1.29

Amundi 1.28

Nuveen, LLC 1.20

Amvescap Plc. 1.20

State Street® SPDR® S&P 500® ETF 1.20

Morgan Stanley - Brokerage Accounts 1.13

Bank of America Corp 1.12

UBS: Global Equity 1.08

D. E. Shaw & Co LP 1.02

Northern Trust Corp 0.97

Federated Hermes Inc 0.89

Vanguard Mid-Cap Growth ETF 0.85

Royal Bank of Canada 0.82

Atlantic Trust Group, LLC 0.81

AQR Capital Management LLC 0.81

BlackRock Mid-Cap Growth Equity Instl 0.80

State Street®HlthCrSelSectSPDR®ETF 0.75

iShares Russell Mid-Cap Growth ETF 0.68

Invesco S&P 500® Equal Weight ETF 0.65

Harbor Capital Appreciation Instl 0.64

Vanguard Institutional Index I 0.58

Xtrackers MSCI World Swap ETF 1C 0.56

State St S&P 500® Indx SL Cl III 0.54

AllianceBernstein US L/C Growth Eqty MF 0.52

JPM US Mid Cap Growth-Composite 0.47

DexCom, Inc. Market Status

Strong Buy: 17

Buy: 6

Hold: 3

Sell: 0

Strong Sell: 0

DexCom, Inc. Fundamentals

Market Cap 26111.59 M

PB Ratio 9.4282

PE Ratio 32.1875

Enterprise Value 25280.86 M

Total Assets 6339.90 M

Volume 8047275

DexCom, Inc. Company Financials

Annual Revenue FY25:4662000000 4662.0M, FY24:4033000000 4033.0M, FY23:3403000000 3403.0M, FY22:2909800000 2909.8M, FY21:2448500000 2448.5M

Annual Profit FY25:2801900000 2801.9M, FY24:2465700000 2465.7M, FY23:2173600000 2173.6M, FY22:1883100000 1883.1M, FY21:1680500000 1680.5M

Annual Net worth FY25:836300000 836.3M, FY24:576200000 576.2M, FY23:377000000 377.0M, FY22:341200000 341.2M, FY21:154700000 154.7M

Quarterly Revenue Q4/2025:1259600000 1259.6M, Q3/2025:1209300000 1209.3M, Q2/2025:1157100000 1157.1M, Q1/2025:1036000000 1036.0M, Q4/2024:1113500000 1113.5M

Quarterly Profit Q4/2025:792700000 792.7M, Q3/2025:731400000 731.4M, Q2/2025:688800000 688.8M, Q1/2025:589000000 589.0M, Q4/2024:654000000 654.0M

Quarterly Net worth Q4/2025:267300000 267.3M, Q3/2025:283800000 283.8M, Q2/2025:179800000 179.8M, Q1/2025:105400000 105.4M, Q4/2024:151700000 151.7M

About DexCom, Inc. & investment objective

Company Information DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Organisation Medical Devices

Employees 11000

Industry Medical Devices

CEO Mr. Jacob Steven Leach

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

DexCom, Inc. FAQs

What is the share price of DexCom, Inc. today?

The current share price of DexCom, Inc. is $67.09.

Can I buy DexCom, Inc. shares in India?

Yes, Indian investors can buy DexCom, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy DexCom, Inc. shares in India?

You can easily invest in DexCom, Inc. shares from India by:

Can I buy fractional shares of DexCom, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of DexCom, Inc.?

DexCom, Inc. has a market cap of $26111.59 M.

In which sector does DexCom, Inc. belong?

DexCom, Inc. operates in the Medical Devices sector.

What documents are required to invest in DexCom, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of DexCom, Inc.?

The PE ratio of DexCom, Inc. is 32.19 and the PB ratio is 9.43.